2015
DOI: 10.1016/j.matchemphys.2015.04.041
|View full text |Cite
|
Sign up to set email alerts
|

Determination of physical properties for β-TCP + chitosan biomaterial obtained on metallic 316L substrates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 42 publications
0
9
0
2
Order By: Relevance
“…Owing to their high biocompatibility and bioactivity, bioceramics based on β-TCP have been widely used for bone repair in clinical applications. [38][39][40][41][42] Some researchers have also considered β-TCP to be osteoinductive. 43 In this study, bone regeneration was assessed by implanting COL/β-TCP and COL disks into critically sized rabbit calvarial defects, which were then studied after 8 weeks.…”
Section: Resultsmentioning
confidence: 99%
“…Owing to their high biocompatibility and bioactivity, bioceramics based on β-TCP have been widely used for bone repair in clinical applications. [38][39][40][41][42] Some researchers have also considered β-TCP to be osteoinductive. 43 In this study, bone regeneration was assessed by implanting COL/β-TCP and COL disks into critically sized rabbit calvarial defects, which were then studied after 8 weeks.…”
Section: Resultsmentioning
confidence: 99%
“…Tricalcium phosphate (TCP) with three polymorphs including α-TCP, β-TCP, and α′-TCP is another well-known bioceramics for bone repair applications. Β-TCP is receiving increasing attention due to its excellent biocompatibility, bioactivity, and bioresorbability [ [34] , [35] , [36] , [37] ]. Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Трикальційфосфат з трьома поліморфними модифікаціями, зокрема, α-ТКФ, β-ТКФ і α'-ТКФ, є ще однією добре відомою біокерамічною речовиною для відновлення кісток. β-TКФ привертає все більшу увагу завдяки його чудовій біосумісності, біоактивності й здатності до біодеградації [75,89].…”
Section: проблеми застосування композиційних імплантів що біодеградують під час лікування переломівunclassified